| abstract |
The present invention relates to a novel group of compounds of formula (I) or salts thereof:n n n [Formula I]n n n n n n n n (Wherein R 1 , R 2 , R 3 , n, A and HET-1 are as defined in the specification)n n n The compound is useful for treating or preventing a disease or medical condition mediated through glucokinase (GLK), such as type 2 diabetes. The invention also relates to a pharmaceutical composition comprising said compound, to a method of treating a GLK mediated disease using said compound and to a method of preparing a compound of formula (I). |